文献速递儿童呼吸儿童感染

COVID-19大流行早期儿童医院住院使用与结局

Inpatient Use and Outcomes at Children's Hospitals During the Early COVID-19 Pandemic.
PubMed 文献 · Pediatrics · 2021-03-23

该回顾性研究基于儿科健康信息系统,比较2020年3月15日至8月29日COVID-19期间与之前3年同期0至18岁儿童住院使用和临床结局。结果显示总住院量下降35.1%,哮喘、毛细支气管炎和肺炎降幅最大,再入院率降低,但住院时长、费用、ICU使用和死亡率与疫情前相似。

要点

  • COVID-19期间儿童医院总住院量较疫情前中位数下降35.1%。
  • 哮喘(81.3%)、毛细支气管炎(80.1%)和肺炎(71.4%)住院降幅最大。
  • 再入院率降低,但住院时长、费用、ICU使用和死亡率与疫情前相似。

核心结论

  • 美国儿童医院在COVID-19大流行早期住院入院量大幅减少,而医院层面结局基本未变。
  • 住院使用影响因疾病而异,呼吸系统疾病住院下降最显著。

研究设计与样本

  • 回顾性研究,使用儿科健康信息系统数据。
  • 比较2020年3月15日至8月29日COVID-19期间与之前3年同期0至18岁儿童住院使用和临床结局。
  • 采用调整的广义线性混合模型分析疫情期与住院使用的关联,并评估15个医学APR-DRG亚组趋势。

主要发现

  • 与疫情前住院中位数相比,总住院量下降35.1%,按APR-DRG下降范围为8.5%至81.3%。
  • 哮喘(81.3%)、毛细支气管炎(80.1%)和肺炎(71.4%)住院下降幅度最大。
  • COVID-19期间总体再入院率较低,但住院时长、费用、ICU使用和死亡率与疫情前相似,部分APR-DRG有变异。

关键数值与推荐

  • 总住院量下降35.1%(与疫情前中位数比较)。
  • 按APR-DRG住院下降范围8.5%至81.3%。
  • 哮喘住院下降81.3%,毛细支气管炎下降80.1%,肺炎下降71.4%。

临床怎么用

  • 儿科医生应了解疫情早期呼吸系统疾病住院显著减少,但其他疾病住院结局基本稳定。
  • 临床可关注再入院率降低及住院资源使用变化,针对不同疾病调整管理策略。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The coronavirus disease 2019 (COVID-19) pandemic has led to changes in health care use, including decreased emergency department visits for children. In this study, we sought to describe the impact of the COVID-19 pandemic on inpatient use within children's hospitals. METHODS: We performed a retrospective study using the Pediatric Health Information System. We compared inpatient use and clinical outcomes for children 0 to 18 years of age during the COVID-19 period (March 15 to August 29, 2020) to the same time frame in the previous 3 years (pre-COVID-19 period). Adjusted generalized linear mixed models were used to examine the association of the pandemic period with inpatient use. We assessed trends overall and for a subgroup of 15 medical All Patient Refined Diagnosis Related Groups (APR-DRGs). RESULTS: We identified 424 856 hospitalizations (mean: 141 619 hospitalizations per year) in the pre-COVID-19 period and 91 532 in the COVID-19 period. Compared with the median number of hospitalizations in the pre-COVID-19 period, we observed declines in hospitalizations overall (35.1%), and by APR-DRG (range: 8.5%-81.3%) with asthma (81.3%), bronchiolitis (80.1%), and pneumonia (71.4%) experiencing the greatest declines. Overall readmission rates were lower during the COVID-19 period; however, other outcomes, including length of stay, cost, ICU use, and mortality remained similar to the pre-COVID-19 period with some variability by APR-DRGs. CONCLUSIONS: US children's hospitals observed substantial reductions in inpatient admissions with largely unchanged hospital-level outcomes during the COVID-19 pandemic. Although the impact on use varied by condition, the most notable declines were related to inpatient admissions for respiratory conditions, including asthma, bronchiolitis, and pneumonia.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Markham JL, Richardson T, DePorre A, et al. Inpatient Use and Outcomes at Children's Hospitals During the Early COVID-19 Pandemic. Pediatrics. 2021. PMID: 33757994. doi:10.1542/peds.2020-044735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。